HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard G Ellenbogen Selected Research

Chlorotoxin

12/2015Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma.
10/2014Redox-responsive magnetic nanoparticle for targeted convection-enhanced delivery of O6-benzylguanine to brain tumors.
11/2010Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery.
11/2010Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior.
8/2010Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma.
4/2010PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo.
8/2009Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier.
8/2008Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles.
3/2008In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes.
7/2007Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard G Ellenbogen Research Topics

Disease

42Neoplasms (Cancer)
01/2022 - 08/2003
15Glioblastoma (Glioblastoma Multiforme)
02/2021 - 02/2008
10Glioma (Gliomas)
07/2020 - 04/2005
9Brain Neoplasms (Brain Tumor)
12/2020 - 04/2005
8Craniosynostoses (Craniosynostosis)
07/2021 - 09/2003
6Syringomyelia (Morvan's Disease)
04/2022 - 08/2011
6Medulloblastoma
08/2012 - 08/2003
5Arnold-Chiari Malformation (Arnold-Chiari Syndrome)
04/2022 - 02/2012
4Traumatic Brain Injuries (Traumatic Brain Injury)
05/2018 - 01/2007
3Neoplasm Metastasis (Metastasis)
11/2021 - 07/2011
3Hydrocephalus (Hydrocephaly)
10/2017 - 04/2010
3Aneurysm (Aneurysms)
01/2012 - 06/2008
3Hemorrhage
08/2011 - 03/2005
2Intracranial Hypertension
12/2021 - 10/2015
2Astrocytoma (Pilocytic Astrocytoma)
11/2021 - 10/2018
2Ganglioglioma
11/2021 - 10/2018
2Scoliosis
06/2021 - 10/2020
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 11/2017
2Chronic Traumatic Encephalopathy
01/2021 - 01/2017
2Drug Resistant Epilepsy
01/2020 - 01/2014
2Ataxia (Dyssynergia)
10/2017 - 08/2011
2Wounds and Injuries (Trauma)
01/2017 - 01/2007
2Seizures (Absence Seizure)
10/2015 - 11/2006
2Breast Neoplasms (Breast Cancer)
07/2014 - 03/2012
1Arteriovenous Malformations (Arteriovenous Malformation)
12/2021
1Hematoma
12/2021
1Epilepsy (Aura)
09/2021
1Unconsciousness (Loss of Consciousness)
01/2021
1Gliosis
01/2021
1Neurologic Manifestations (Neurological Manifestations)
12/2020
1Bites and Stings (Sting)
10/2020
1Melanoma (Melanoma, Malignant)
10/2020
1Thrombocytopenia (Thrombopenia)
07/2020
1Vomiting
07/2020
1Nausea
07/2020
1Hypoxia (Hypoxemia)
05/2018
1Dementia (Dementias)
11/2017
1Hemangioblastoma
10/2017

Drug/Important Bio-Agent (IBA)

10ChlorotoxinIBA
12/2015 - 07/2007
9ChitosanIBA
12/2016 - 08/2009
7Pharmaceutical PreparationsIBA
02/2021 - 02/2008
6Temozolomide (Temodar)FDA LinkGeneric
02/2021 - 04/2005
5Small Interfering RNA (siRNA)IBA
02/2021 - 11/2010
5Proteins (Proteins, Gene)FDA Link
10/2020 - 08/2003
5LigandsIBA
12/2016 - 11/2004
4Biological ProductsIBA
02/2021 - 03/2008
4RNA (Ribonucleic Acid)IBA
01/2021 - 11/2010
4DNA (Deoxyribonucleic Acid)IBA
11/2018 - 08/2010
4Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2015 - 08/2009
4Peptides (Polypeptides)IBA
10/2014 - 03/2008
3CytokinesIBA
10/2020 - 07/2014
3AlginatesIBA
10/2016 - 11/2014
3A-factor (Streptomyces)IBA
01/2016 - 10/2005
3Ethylene Glycol (Monoethylene Glycol)IBA
07/2014 - 03/2008
3HydrogelsIBA
07/2014 - 11/2012
3Contrast MediaIBA
08/2008 - 07/2007
24- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
11/2021 - 10/2018
2Interleukin-12 (IL 12)IBA
10/2020 - 10/2020
2AntigensIBA
10/2020 - 03/2012
2Oxygen (Dioxygen)IBA
05/2018 - 12/2010
2Biomarkers (Surrogate Marker)IBA
01/2018 - 04/2005
2PolyethyleneimineIBA
12/2015 - 05/2011
2O(6)-benzylguanineIBA
10/2014 - 04/2005
2EndonucleasesIBA
11/2011 - 10/2005
2IntegrinsIBA
11/2010 - 02/2008
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
11/2010 - 07/2007
2CY5.5 cyanine dyeIBA
04/2010 - 07/2007
2Cisplatin (Platino)FDA LinkGeneric
01/2006 - 03/2004
1SynucleinsIBA
01/2021
1Apolipoproteins E (ApoE)IBA
01/2021
1Free RadicalsIBA
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1Chimeric Antigen ReceptorsIBA
10/2020
1Interferon-gamma (Interferon, gamma)IBA
10/2020
1InterleukinsIBA
10/2020
1Neoplasm Antigens (Tumor Antigens)IBA
10/2020
1AntibodiesIBA
10/2020
1Epidermal Growth Factor (EGF)IBA
10/2020
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2020
1ChemokinesIBA
10/2020
1epidermal growth factor receptor VIIIIBA
10/2020
1Irinotecan (Camptosar)FDA LinkGeneric
07/2020
1dipinacoline glutamateIBA
07/2020
1Bevacizumab (Avastin)FDA Link
07/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2018
1Amyloid beta-PeptidesIBA
11/2017
1Nucleic AcidsIBA
10/2017

Therapy/Procedure

16Therapeutics
10/2020 - 02/2008
11Drug Therapy (Chemotherapy)
01/2022 - 03/2004
10Decompression
04/2022 - 09/2010
7Sutures (Suture)
07/2021 - 09/2003
5Radiotherapy
12/2020 - 11/2011
5Immunotherapy
10/2020 - 07/2014
5Craniotomy
10/2017 - 03/2005
3Hemispherectomy
09/2021 - 01/2014
2Surgical Decompression
12/2021 - 01/2008
2Length of Stay
10/2017 - 01/2017
2Ligation
09/2010 - 10/2007
1Salvage Therapy
01/2019
1Resuscitation
05/2018